Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Maxim Group

Investor type Venture Capital


Unlock datapoints

Portfolio analytics



News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Looking for a perfect list of funds?

Get recommendations from our smart algorithm

Get the list
Total investments 7
Average round size
The average size of a deal this fund participated in
Portfolio companies 7
Rounds per year 0.33
Lead investments 3
Exits 4
Key employees 12
Stages of investment
Late Stage Venture

Areas of investment

  • Health Care
  • Biotechnology
  • Medical
  • Medical Device
  • Genetics

Maxim Group is the famous Corporate Investor, which was founded in 2002. The main department of described Corporate Investor is located in the New York. The venture was found in North America in United States.

Besides, a startup needs to be aged 6-10 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular portfolio startups of the fund, we may highlight ContraFect, Abeona Therapeutics, BillMyParents. We can highlight the next thriving fund investment areas, such as Young Adults, E-Commerce. The fund has no exact preference in some founders of portfolio startups. In case when startup counts 4 or 5+ of the founder, the chance for it to get the investment is meager.

The usual cause for the fund is to invest in rounds with 2 partakers. Despite the Maxim Group, startups are often financed by Stop Sanfilippo, George Soros, Equity Source Partners. The meaningful sponsors for the fund in investment in the same round are RBC Capital Markets, Jefferies, H. C. Wainwright & Co.. In the next rounds fund is usually obtained by Venrock, Sofinnova Investments, New Leaf Venture Partners.

The overall number of key employees were 12.

Opposing the other organizations, this Maxim Group works on 11 percentage points more the average amount of lead investments. The high activity for fund was in 2017. The fund is constantly included in less than 2 deals per year. The increased amount of exits for fund were in 2015. Considering the real fund results, this Corporate Investor is 40 percentage points more often commits exit comparing to other organizations. The usual things for fund are deals in the range of 10 - 50 millions dollars.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Maxim Group:
Typical Co-investors
Maxim Group is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Maxim Group:

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Argoquest Israel, Tel Aviv, Tel Aviv District
Black Fish China, Jiangsu, Nanjing
Blockchain Ventures California, Palo Alto, United States
Geneva Venture Partners Las Vegas, Nevada, United States
Green Campus Innovations -
INCapital Ventures Canada, Ontario, Toronto
Kenetic China, Hong Kong, Hong Kong Island
Lanai Partners Barcelona, Catalonia, Spain
NGK SPARK PLUG CO Aichi Prefecture, Japan, Nagoya
Portage Partners New York, New York, United States
PT. Astra International Tbk - TSO Salemba Indonesia, Jakarta, Jakarta Raya
Rowny Capital District of Columbia, United States, Washington
Runa Capital California, Palo Alto, United States
Shanghai Hongjia Asset Management Co. China, Shanghai
Sutardja Ventures -
Teddy Sagi Group Cyprus, Nicosia
Tianjin Junding Dianlian Qiye Guanli Zixun Zhongxin China, Tianjin, Wuqing
TruePosition Berwyn, Pennsylvania, United States
Zenium Technology Partners(ZTP) England, London, United Kingdom
Zhisland Capital Beijing, Beijing, China

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation


3D Printing
Food Processing
$6M06 Jan 2023 Israel, North District, Israel

Nacuity Pharmaceuticals

Health Care
$16M15 Jun 2022 Fort Worth, Texas, United States

Alveo Technologies

Health Care
Medical Device
$38M05 Jan 2018 United States, " United States"}

Abeona Therapeutics

Health Care
Medical Device
$92M19 Oct 2017 New York, United States

Edge Therapeutics

Health Care
$18M04 Jun 2013 New Jersey, United States


Health Care
$12M15 Sep 2011 Yonkers, New York, United States


Financial Services
Young Adults
$3M24 Nov 2010 San Diego, California, United States


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Maxim Group?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: